Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network

<strong>Introduction</strong> Rapid Point of Care Testing (POCT) for influenza could be used to provide information on influenza vaccine effectiveness (IVE) as well as influencing clinical decision-making in primary care. <br> <strong>Methods</strong> We undertook a tes...

Cijeli opis

Bibliografski detalji
Glavni autori: de Lusignan, S, Hoang, U, Liyanage, H, Tripathy, M, Sherlock, J, Joy, M, Ferreira, F, Diez-Domingo, J, Clark, T
Format: Journal article
Jezik:English
Izdano: Public Library of Science 2021
_version_ 1826257114165673984
author de Lusignan, S
Hoang, U
Liyanage, H
Tripathy, M
Sherlock, J
Joy, M
Ferreira, F
Diez-Domingo, J
Clark, T
author_facet de Lusignan, S
Hoang, U
Liyanage, H
Tripathy, M
Sherlock, J
Joy, M
Ferreira, F
Diez-Domingo, J
Clark, T
author_sort de Lusignan, S
collection OXFORD
description <strong>Introduction</strong> Rapid Point of Care Testing (POCT) for influenza could be used to provide information on influenza vaccine effectiveness (IVE) as well as influencing clinical decision-making in primary care. <br> <strong>Methods</strong> We undertook a test negative case control study to estimate the overall and age-specific (6 months-17 years, 18–64 years, ≥65 years old) IVE against medically attended POCT-confirmed influenza. The study took place over the winter of 2019–2020 and was nested within twelve general practices that are part of the Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC), the English sentinel surveillance network. <br> <strong>Results</strong> 648 POCT were conducted. 193 (29.7%) of those who were swabbed had received the seasonal influenza vaccine. The crude unadjusted overall IVE was 46.1% (95% CI: 13.9–66.3). After adjusting for confounders the overall IVE was 26.0% (95% CI: 0–65.5). In total 211 patients were prescribed an antimicrobial after swab testing. Given a positive influenza POCT result, the odds ratio (OR) of receiving an antiviral was 21.1 (95%CI: 2.4–182.2, p = <0.01) and the OR of being prescribed an antibiotic was 0.6 (95%CI: 0.4–0.9, p = <0.01). <br> <strong>Discussion</strong> Using influenza POCT in a primary care sentinel surveillance network to estimate IVE is feasible and provides comparable results to published IVE estimates. A further advantage is that near patient testing of influenza is associated with improvements in appropriate antiviral and antibiotic use. Larger, randomised studies are needed in primary care to see if these trends are still present and to explore their impact on outcomes.
first_indexed 2024-03-06T18:12:59Z
format Journal article
id oxford-uuid:03a5d264-1f89-420d-b48a-e357d00c0d3f
institution University of Oxford
language English
last_indexed 2024-03-06T18:12:59Z
publishDate 2021
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:03a5d264-1f89-420d-b48a-e357d00c0d3f2022-03-26T08:47:30ZUsing Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance networkJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:03a5d264-1f89-420d-b48a-e357d00c0d3fEnglishSymplectic ElementsPublic Library of Science2021de Lusignan, SHoang, ULiyanage, HTripathy, MSherlock, JJoy, MFerreira, FDiez-Domingo, JClark, T<strong>Introduction</strong> Rapid Point of Care Testing (POCT) for influenza could be used to provide information on influenza vaccine effectiveness (IVE) as well as influencing clinical decision-making in primary care. <br> <strong>Methods</strong> We undertook a test negative case control study to estimate the overall and age-specific (6 months-17 years, 18–64 years, ≥65 years old) IVE against medically attended POCT-confirmed influenza. The study took place over the winter of 2019–2020 and was nested within twelve general practices that are part of the Oxford-Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC), the English sentinel surveillance network. <br> <strong>Results</strong> 648 POCT were conducted. 193 (29.7%) of those who were swabbed had received the seasonal influenza vaccine. The crude unadjusted overall IVE was 46.1% (95% CI: 13.9–66.3). After adjusting for confounders the overall IVE was 26.0% (95% CI: 0–65.5). In total 211 patients were prescribed an antimicrobial after swab testing. Given a positive influenza POCT result, the odds ratio (OR) of receiving an antiviral was 21.1 (95%CI: 2.4–182.2, p = <0.01) and the OR of being prescribed an antibiotic was 0.6 (95%CI: 0.4–0.9, p = <0.01). <br> <strong>Discussion</strong> Using influenza POCT in a primary care sentinel surveillance network to estimate IVE is feasible and provides comparable results to published IVE estimates. A further advantage is that near patient testing of influenza is associated with improvements in appropriate antiviral and antibiotic use. Larger, randomised studies are needed in primary care to see if these trends are still present and to explore their impact on outcomes.
spellingShingle de Lusignan, S
Hoang, U
Liyanage, H
Tripathy, M
Sherlock, J
Joy, M
Ferreira, F
Diez-Domingo, J
Clark, T
Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network
title Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network
title_full Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network
title_fullStr Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network
title_full_unstemmed Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network
title_short Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network
title_sort using point of care testing to estimate influenza vaccine effectiveness in the english primary care sentinel surveillance network
work_keys_str_mv AT delusignans usingpointofcaretestingtoestimateinfluenzavaccineeffectivenessintheenglishprimarycaresentinelsurveillancenetwork
AT hoangu usingpointofcaretestingtoestimateinfluenzavaccineeffectivenessintheenglishprimarycaresentinelsurveillancenetwork
AT liyanageh usingpointofcaretestingtoestimateinfluenzavaccineeffectivenessintheenglishprimarycaresentinelsurveillancenetwork
AT tripathym usingpointofcaretestingtoestimateinfluenzavaccineeffectivenessintheenglishprimarycaresentinelsurveillancenetwork
AT sherlockj usingpointofcaretestingtoestimateinfluenzavaccineeffectivenessintheenglishprimarycaresentinelsurveillancenetwork
AT joym usingpointofcaretestingtoestimateinfluenzavaccineeffectivenessintheenglishprimarycaresentinelsurveillancenetwork
AT ferreiraf usingpointofcaretestingtoestimateinfluenzavaccineeffectivenessintheenglishprimarycaresentinelsurveillancenetwork
AT diezdomingoj usingpointofcaretestingtoestimateinfluenzavaccineeffectivenessintheenglishprimarycaresentinelsurveillancenetwork
AT clarkt usingpointofcaretestingtoestimateinfluenzavaccineeffectivenessintheenglishprimarycaresentinelsurveillancenetwork